HETEROGENEITY IN THE IN-VITRO SURVIVAL AND PROLIFERATION OF HUMAN SEMINOMA CELLS

被引:20
|
作者
OLIE, RA
LOOIJENGA, LHJ
DEKKER, MC
DEJONG, FH
VANDISSELEMILIANI, F
DEROOIJ, DG
VANDERHOLT, B
OOSTERHUIS, JW
机构
[1] ERASMUS UNIV ROTTERDAM,DEPT ENDOCRINOL & REPROD,3000 DR ROTTERDAM,NETHERLANDS
[2] UNIV UTRECHT,DEPT CELL BIOL,UTRECHT,NETHERLANDS
[3] DR DANIEL DEN HOED CANC CTR,DEPT STAT,3008 AE ROTTERDAM,NETHERLANDS
关键词
HUMAN SEMINOMA; IN VITRO CULTURE; PROLIFERATION; GROWTH FACTORS;
D O I
10.1038/bjc.1995.4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The in vitro culture conditions allowing survival and initial proliferation of murine primordial germ cells from 10.5 days post coitum embryos, which include the use of a murine embryonal fibroblast (STO) feeder, were applied to 21 human seminomas, composed of tumour cells which are considered as the malignant counterparts of human primordial germ cells. Cells from 18 seminomas attached poorly to STO, and only a few survived through day 10. In contrast, three seminomas showed a higher degree of attachment. Two of them showed initial proliferation and enhanced survival: 30 days for tumour SE1 and 25 days for tumour SE3. Tumour SEI was more extensively studied, using the culture conditions allowing the derivation of pluripotent embryonic stem cells from 8.5 days post coitum murine primordial germ cells, which include the use of STO feeder, stem cell factor, leukaemia inhibitory factor and basic fibroblast growth factor. The presence of stem cell factor was necessary and sufficient for colonies of tumour cells to form during the first 3 days of culture. While the cell number decreased after day 3 in medium without fetal calf serum, it increased until day 9 in medium containing fetal calf serum. No reprogramming of SE1 cells to pluripotent stem cells was observed. Our data indicate that seminomas form a tumour population with a heterogeneous in vitro behaviour not equivalent to that of 8.5-10.5 days post coitum murine primordial germ cells.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [1] SURVIVAL AND PROLIFERATION OF RAT GONOCYTES IN-VITRO
    VANDISSELEMILIANI, FMF
    DEBOERBROUWER, M
    SPEK, ER
    VANDERDONK, JA
    DEROOIJ, DG
    CELL AND TISSUE RESEARCH, 1993, 273 (01) : 141 - 147
  • [2] SURVIVAL AND PROLIFERATION IN-VITRO OF LONG-TERM HEMATOPOIETIC REPOPULATING CELLS
    THORSTEINSDOTTIR, U
    SAUVAGEAU, G
    HUMPHRIES, RK
    BLOOD, 1994, 84 (10) : A542 - A542
  • [3] IN-VITRO SENSITIVITY OF HUMAN CELLS TO LYMPHOCYTE PROLIFERATION INHIBITORY FACTOR
    GREEN, JA
    GREEN, JR
    COOPERBAND, SR
    KIBRICK, S
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1972, 49 (03): : 631 - +
  • [4] IN-VITRO STUDIES ON HETEROGENEITY OF HUMAN THYMOCYTES
    AUGUST, C
    ROSEN, F
    MERLER, E
    FEDERATION PROCEEDINGS, 1970, 29 (02) : A698 - +
  • [5] PROLIFERATION AND DIFFERENTIATION OF GLIAL CELLS IN-VITRO
    MANUELIDIS, L
    MANUELIDIS, EE
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1972, 31 (01): : 193 - +
  • [6] PROLIFERATION AND DIFFERENTIATION OF PIGMENT CELLS IN-VITRO
    KITANO, Y
    HU, F
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1970, 55 (06) : 444 - &
  • [7] RETINOIC ACID INFLUENCES THE PROLIFERATION OF EMBRYONIC HUMAN RETINAL CELLS IN-VITRO
    KELLEY, MW
    TURNER, JK
    REH, TA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 2075 - 2075
  • [8] In vitro survival, RAS mutations, apoptosis and activation of the SAPK-pathway in human seminoma cells
    Oosterhuis, JW
    Gillis, AJM
    Looijenga, LHJ
    GERM CELL TUMOURS IV, 1998, : 51 - 57
  • [9] The control of proliferation, survival and apoptosis in human multiple myeloma cells in vitro
    Nilsson, K
    Georgii-Hemming, P
    Spets, H
    Jernberg-Wiklund, H
    MECHANISMS OF B CELL NEOPLASIA 1998, 1999, 246 : 325 - 333
  • [10] Nanoscale topography promotes the survival and proliferation of human beta cells in vitro
    Perego, C.
    Di Cairano, E. S.
    Moretti, S.
    Bertuzzi, F.
    Tedeschi, G.
    Sogne, E.
    Piazzoni, C.
    Milani, P.
    Lenardi, C.
    DIABETOLOGIA, 2016, 59 : S221 - S221